Statistics from Altmetric.com
The implantation of drug-eluting stents (DES) has become a standard treatment for the management of patients with coronary artery disease. The use of dual antiplatelet therapy (DAPT) is critically important for the prevention of coronary stent thrombosis. Current clinical guidelines recommend at least 6–12 months of treatment after DES implantation; however, a longer duration of DAPT may be beneficial.1
This study is an international, randomised, placebo-controlled trial that was designed to determine the benefits and risks of continuing DAPT beyond …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.